Actively Recruiting

Phase Not Applicable
Age: 50Years +
All Genders
ID05820919

Enhancing Sleep Quality for Nursing Home Residents With Dementia: Pragmatic Trial of an Evidence-Based Frontline Huddling Program

Led by University of Alabama, Tuscaloosa · Updated on 2024-03-12

456

Participants Needed

3

Research Sites

60 weeks

Total Duration

On this page

Sponsors

U

University of Alabama, Tuscaloosa

Lead Sponsor

U

University of Massachusetts, Lowell

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to improve clinical outcomes for nursing home residents aged 50 and older who have Alzheimer's disease or related dementias and experience sleep problems. The study focuses on testing an evidence-based intervention designed to enhance sleep quality in this vulnerable group, addressing issues caused by nursing home routines that often disturb residents' sleep. The investigation also explores how well the intervention can be implemented and sustained over time in real-world nursing home settings. The intervention being studied is called the LOCK sleep program, which trains frontline nursing home staff to use huddling techniques based on strengths-based learning, teamwork, and systematic observation. Each nursing home acts as its own control, with one week of baseline data collection followed by a ten-week active intervention phase and a five-week sustainment phase. The LOCK program teaches staff to collaboratively solve sleep challenges and promote best practices for sleep and meaningful daytime activity in residents. Participants will be monitored over a 15-week period, during which sleep will be measured using actigraphy. Researchers will also track secondary outcomes such as use of psychotropic medications, pain treatment and reports, and decline in activities of daily living. The study involves data collection and observation to assess the program's impact, sustainment, and factors influencing implementation across 24 nursing homes. Safety and adherence are monitored throughout the study period, with all nursing home residents eligible for the intervention once baseline data is collected.

CONDITIONS

Brief Title

Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

Who Can Participate

Age: 50Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Nursing home residents aged 50 years or older
  • Diagnosed with Alzheimer disease or related dementia
  • Identified by nursing home staff as having sleep problems
  • Participation in frontline LOCK sleep huddles
Not Eligible

You will not qualify if you...

  • High risk of untreated obstructive sleep apnea (OSA)
  • Persistent bilateral resting tremor or paralysis in both arms, including some Parkinson's disease cases due to measurement inaccuracies

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Control Period

Duration - 1 week

Participants serve as their own control during which baseline data on sleep and related outcomes are collected.

1 week of baseline data collection with no intervention

Intervention

Duration - 10 weeks

Participants receive the LOCK sleep program involving frontline staff huddling to improve sleep quality through teamwork and evidence-based practices.

Weekly visits during the active intervention phase

Sustainment

Duration - 5 weeks

Participants continue to be observed during a 5-week period to assess the sustainability of the LOCK sleep program benefits.

Weekly visits during the sustainment phase

Trial Site Locations

Total: 3 locations

1

Vivage/Beecan Corporation

Lakewood, Colorado, United States, 80228

Actively Recruiting

2

National HealthCare Corporation

Murfreesboro, Tennessee, United States, 37130

Actively Recruiting

3

Caraday Healthcare, LLC

San Marcos, Texas, United States, 78666

Actively Recruiting

Loading map...

Research Team

L

Lynn Snow, PhD

B

Brian Cox, MS

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Comparison of Cardiac [18F]-MFBG PET Versus [123I]-MIBG SPEC...

Parkinson Disease

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here